Literature DB >> 8697982

[Evaluation of combined test of sequential fecal occult blood and albumin in the screening of colorectal neoplasms].

S Li1, C Zhang, E Xu.   

Abstract

Fecal albumin test was developed and the combined use of sequential occult blood test and albumin test (SA) was evaluated and compared with sequential fecal occult blood test (S) in 365 cases diagnosed clinically and pathologically and in 883 asymptomatic individuals. In the former group, the sensitivity of detection of colorectal cancer was: 50.7% (37/73) with S and 87.7% (64/73) with SA (P < 0.001), and that of the adenoma was: 8.1% (6/74) with S and 36.5% (27/74) with SA (P < 0.001). In the latter group 2 of 3 cancer patients were detected with S while all with SA, and the detection rate of adenoma was: 4.7% (4/85) with S and 42.4% (36/85) with SA (P < 0.001) it is suggested that the additional use of fecal albumin test is of help in detecting precancerous inflammatory bowel lesions without bleeding.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8697982

Source DB:  PubMed          Journal:  Zhonghua Zhong Liu Za Zhi        ISSN: 0253-3766


  3 in total

1.  Test performance of faecal occult blood testing for the detection of bowel cancer in people with chronic kidney disease (DETECT) protocol.

Authors:  Germaine Wong; Kirsten Howard; Jeremy R Chapman; Allison Tong; Michael J Bourke; Andrew Hayen; Petra Macaskill; Richard L Hope; Narelle Williams; Anh Kieu; Richard Allen; Steven Chadban; Carol Pollock; Angela Webster; Simon D Roger; Jonathan C Craig
Journal:  BMC Public Health       Date:  2011-06-29       Impact factor: 3.295

Review 2.  Early diagnosis for colorectal cancer in China.

Authors:  Ya-Li Zhang; Zhen-Su Zhang; Ba-Ping Wu; Dian-Yuan Zhou
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

3.  Screening and early diagnosis of colorectal cancer in China: a 12 year retrospect (1994-2006).

Authors:  Shirong Li; Jiheng Wang; Yuanyuan Lu; Daiming Fan
Journal:  J Cancer Res Clin Oncol       Date:  2007-05-15       Impact factor: 4.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.